FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely neurology, and enables predicting functional recovery of patients with ischemic stroke. That is ensured by a clinical neurological examination and a level of activation of the patient's immune system. On the first day of the acute period of the disease by measuring a patient's blood plasma enzymatic activity of leukocyte elastase (LE), functional activity α1-proteinase inhibitor (α1-PI), level of autoantibodies (AB) to neurotrophin S100b and myelin basic protein (MBP) and determining functional recovery probability in accordance with formula
where p is functional recovery probability; e is the base of the natural logarithm, 10.9 is the regression constant, 0.03 is the coefficient with the enzymatic activity index LE, 0.17 is coefficient of functional activity index α1-PI, 9.1 – coefficient with the level of autoantibodies to neurotrophin S100b AB, 7.4 – coefficient with the level of autoantibodies to the main protein of myelin MBP. Result of measuring enzymatic activity LE are expressed in units [nmol/min×ml]. Functional activity measurement result α1-PI expressed in units of [IU/ml]. Result of measuring the level of autoantibodies AB to neuroantigens is expressed in units of optical density (units OP). If p≥0.50, then functional recovery is possible, and with p<0.50 – functional recovery of the patient is unlikely.
EFFECT: invention has high sensitivity (77,8 %) and specificity (83,3 %) of predicting the possibility of functional recovery in the acute period of ischemic stroke.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING NEUROLOGICAL RECOVERY FROM THE 14TH TO THE 90TH DAYS OF ISCHEMIC STROKE OF THE BRAIN | 2021 |
|
RU2764355C1 |
METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
METHOD FOR PREDICTING RECOVERY OF SENSORIMOTOR FUNCTIONS IN PATIENTS WITH ACUTE ISCHEMIC STROKE AFTER EARLY REHABILITATION | 2021 |
|
RU2753140C1 |
METHOD FOR PREDICTING THE RECOVERY OF FUNCTIONS IMPAIRED AS A RESULT OF CEREBRAL STROKE IN ELDERLY MEN | 2022 |
|
RU2781115C1 |
METHOD FOR PREDICTING FUNCTIONAL RECOVERY AFTER ISCHEMIC STROKE | 2024 |
|
RU2825714C1 |
METHOD OF LABORATORY DETECTION OF CONSEQUENCES OF PERINATAL CENTRAL NERVOUS SYSTEM AFFECTIONS AND SEVERITY DETERMINATION IN CHILDREN | 2010 |
|
RU2425371C1 |
METHOD FOR PREDICTION OF FUNCTIONAL RESTORATION IN PATIENTS WITH ISCHEMIC STROKE | 2017 |
|
RU2631745C1 |
DIAGNOSTIC TECHNIQUE FOR ASTHENIC SYNDROME IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2709105C1 |
METHOD FOR PREDICTING THE LIKELIHOOD OF DEVELOPING ALZHEIMER'S DISEASE (AD) | 2017 |
|
RU2663451C1 |
Authors
Dates
2019-07-16—Published
2018-10-19—Filed